Delayed Recovery from General Anaesthesia: A Post-operative Diagnostic Dilemma and Implications of ICU Management of Serotonin Toxicity. Case report

1. Kuriloff DB, Sanborn KV. Rapid intraoperative localization of parathyroid glands using methylene blue infusion. Otolaryngology- Head Neck Surgery. 2004;131:616-22.10.1016/j.otohns.2004.04.02615523436Search in Google Scholar

2. Patel HP, Chadwick DR, Harrison BJ, Balasubramanian SP. Systematic review of intravenous methylene blue in parathyroid surgery. Br J Surg. 2012;99:1345-52.10.1002/bjs.881422961511Search in Google Scholar

3. Ramsay RR, Dunford C, Gilman PK. Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction. Br J Pharmacol. 2007;152:946-51.10.1038/sj.bjp.0707430207822517721552Search in Google Scholar

4. Dunkley EJ, Isbister GK, Sibbritt D, et al. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic rules for serotonin toxicity. QJM. 2003;96:635.10.1093/qjmed/hcg10912925718Search in Google Scholar

5. Mowry JB, Spyker DA, Cantilena LR Jr, Bailey JE, Ford M. 2012 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 30th Annual Report. ClinToxicol (Phila). 2013;51:949-1229.10.3109/15563650.2013.86390624359283Search in Google Scholar

6. Shopes E, Wayne Gerard W, Baughman J. Methylene blue encephalopathy: a case report and review of published cases. AANA Journal. 2013;81:215-21.Search in Google Scholar

7. Khan MAS, North AP, Chadwick DR. Prolonged Postoperative Altered Mental Status After Methylene Blue Infusion During Parathyroidectomy: A Case Report and Review of the Literature. Ann R Coll Surg Engl. 2007;89:W9-W11.10.1308/147870807X160434196458617346391Search in Google Scholar

8. Johnson N, Soar J, Robinson S. Concurrent administration of methylene blue and a selective serotonin reuptake inhibitor: a recipe for serotonin syndrome. Journal of the Intensive Care Society. 2012;13:256-8.10.1177/175114371201300318Search in Google Scholar

9. Khavandi A, Whitaker J, Gonna H. Serotonin toxicity precipitated by concomitant use of citalopram and methylene blue. Med J Aust. 2008;189:534-5.10.5694/j.1326-5377.2008.tb02168.x18976207Search in Google Scholar

10. Ng BKW, Cameron AJD. Serotonin syndrome following methylene blue infusion during parathyroidectomy: a case report and literature review. Can J Anaesthesiol. 2008;55:1-5.Search in Google Scholar

11. Martindale SJ, Stedeford JC. Neurological sequelae following methylene blue injection for parathyroidectomy. Anaesthesia. 2003;58:1041-2.10.1046/j.1365-2044.2003.03415_23.x12969068Search in Google Scholar

12. Isbister GK, Buckley NA, Whyte IM. Serotonin toxicity: a practical approach to diagnosis and treatment . Med J Aust. 2007;187:361-5.10.5694/j.1326-5377.2007.tb01282.x17874986Search in Google Scholar

13. MHRA Drug Safety Update. 2009, vol 2 issue 9:3.Search in Google Scholar

14. Methylene blue: Drug Safety Communication - Serious CNS Reactions possible when given to patients taking certain psychiatric medication. July 2011 (updated October 2011)Search in Google Scholar

15. Lead Directorate: Marketed Health Product Directorate. Methylene blue injectable in combination with serotonin reuptake inhibitors - Association with serotonin toxicity - Notice to Hospitals. 2011. Available at: http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2011/14648a-eng.phpSearch in Google Scholar

16. Hall M, Buckley N. Serotonin syndrome. Australian Prescriber. 2003;26:62-3.10.18773/austprescr.2003.044Search in Google Scholar